|
1
|
Okada Y and Tadokoro J: The distribution
of cell fusion capacity among several cell strains or cells caused
by HVJ. Exp Cell Res. 32:417–430. 1963.
|
|
2
|
Okada Y, Yamada K and Tadokoro J: Effect
of antiserum on the cell fusion reaction caused by HVJ. Virology.
22:397–409. 1964.
|
|
3
|
Okada Y, Kim J, Maeda Y and Koseki I:
Specific movement of cell membranes fused with HVJ (Sendai virus).
Proc Natl Acad Sci. 71:2043–2047. 1974.
|
|
4
|
Furusawa M, Nishimura T, Yamaizumi M and
Okada Y: Injection of foreign substances into single cells by cell
fusion. Nature. 249:449–450. 1974.
|
|
5
|
Frye LD and Edidin M: The rapid
intermixing of cell surface antigens after formation of mouse-human
heterokaryons. J Cell Sci. 7:319–335. 1970.
|
|
6
|
Singer SJ and Nicolson GL: The fluid
mosaic model of the structure of cell membranes. Science.
175:720–731. 1972.
|
|
7
|
Rodriguez-Tomé P and Lijnzaad P: The
radiation hybrid database. Nucleic Acids Res. 27:115–118. 1999.
|
|
8
|
Islam MQ, da Meirelles LS, Nardi NB,
Magnusson P and Islam K: Polyethylene glycol-mediated fusion
between primary mouse mesenchymal stem cells and mouse fibroblasts
generates hybrid cells with increased proliferation and altered
differentiation. Stem Cells Dev. 15:905–919. 2006.
|
|
9
|
Galfre G, Howe SC, Milstein C, Butcher GW
and Howard JC: Antibodies to major histocompatibility antigens
produced by hybrid cell lines. Nature. 266:550–552. 1977.
|
|
10
|
Margulies DH: Monoclonal antibodies:
producing magic bullets by somatic cell hybridization. J Immunol.
174:2451–2452. 2005.
|
|
11
|
Wei Y, Li J and Wagner TE: Dendritoma
vaccine for cancer. Curr Can Ther Rev. 5:134–141. 2009.
|
|
12
|
Avigan D, Rosenblatt J and Kufe D:
Dendritic/tumor fusion cells as cancer vaccines. Semin Oncol.
39:287–295. 2012.
|
|
13
|
Browning MJ: Antigen presenting cell/
tumor cell fusion vaccines for cancer immunotherapy. Hum Vaccin
Immunother. 9:1545–1548. 2013.
|
|
14
|
Köhler G and Milstein C: Continuous
cultures of fused cells secreting antibody of predefined
specificity. Nature. 256:495–497. 1975.
|
|
15
|
Anné J and Peberdy JF: Conditions for
induced fusion of fungal protoplasts in polyethylene glycol
solutions. Arch Microbiol. 105:201–205. 1975.
|
|
16
|
Pontecorvo G: Production of mammalian
somatic cell hybrids by means of polyethylene glycol treatment.
Somatic Cell Genet. 1:397–400. 1975.
|
|
17
|
Zimmermann U, Vienken J, Halfmann J and
Emeis CC: Electrofusion: a novel hybridization technique. Adv
Biotechnol Processes. 4:79–150. 1985.
|
|
18
|
Hiraoka K, Yamamota S, Otsuru S, Nakai S,
Tamai K, Morishita R, Ogihara T and Kaneda Y: Enhanced
tumor-specific long-term immunity of hemaggluttinating virus of
Japan-mediated dendritic cell-tumor fused cell vaccination by
coadministration with CpG oligodeoxynucleotides. J Immunol.
173:4297–4307. 2004.
|
|
19
|
Uekawa N, Nishioka T, Terauchi K, Ohta S,
Sugimoto M, Shimada J and Maruyama M: Generation and
characterization of novel monoclonal antibodies against murine and
human TARSH proteins. Hybridoma (Larchmt). 26:381–385. 2007.
|
|
20
|
Bakker Schut TC, Kraan YM, Barlag W, de
Leij L, de Grooth BG and Greve J: Selective electrofusion of
conjugated cells in flow. Biophys J. 65:568–572. 1993.
|
|
21
|
Tomita M and Tsong TY: Selective
production of hybridoma cells: antigenic-based pre-selection of B
lymphocytes for electrofusion with myeloma cells. Biochim Biophys
Acta. 1055:199–206. 1990.
|
|
22
|
Kimura Y, Gel M, Techaumnat B, Oana H,
Kotera H and Washizu M: Dielectrophoresis-assisted massively
parallel cell pairing and fusion based on field constriction
created by a micro-orifice array sheet. Electrophoresis.
32:2496–2501. 2011.
|
|
23
|
Skelley AM, Kirak O, Suh H, Jaenisch R and
Voldman J: Microfluidic control of cell pairing and fusion. Nat
Methods. 6:147–152. 2009.
|
|
24
|
Lutz MB, Kukutsch N, Ogilvie AL, Rössner
S, Koch F, Romani N and Schuler G: An advanced culture method for
generating large quantities of highly pure dendritic cells from
mouse bone marrow. J Immunol Methods. 223:77–92. 1999.
|
